|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Synuclein
1 Departments of Physiology, Biophysics, and Systems Biology and 2 Department of Biochemistry, Weill Medical College of Cornell University, New York, New York 10021, USA
Reprint requests to: David Eliezer, Department of Biochemistry, Weill Medical College of Cornell University, 1300 York Avenue, New York, NY 10021, USA; e-mail: dae2005{at}med.cornell.edu; fax: (212) 746-4843.
(RECEIVED November 24, 2004; FINAL REVISION January 6, 2005; ACCEPTED January 6, 2005)
| Abstract |
|---|
|
|
|---|
-Synuclein (aS) is a synaptic vesicle-associated regulator of synaptic strength and dopamine homeostasis with a pathological role in Parkinsons disease. The normal function of aS depends on a membrane-associated conformation that is adopted upon binding to negatively charged lipid surfaces. Previously we found that the membrane-binding domain of aS is helical and suggested that it may exhibit an unusual structural periodicity. Here we present a study of the periodicity, topology, and dynamics of detergent micelle-bound aS using paramagnetic spin labels embedded in the micelle or attached to the protein. We show that the helical region of aS completes three full turns every 11 residues, demonstrating the proposed 11/3 periodicity. We also find that the membrane-binding domain is partially buried in the micelle surface and bends toward the hydrophobic interior, but does not traverse the micelle. Deeper submersion of certain regions within the micelle, including the unique lysine-free sixth 11-residue repeat, is observed and may be functionally important. There are no long-range tertiary contacts within this domain, indicating a highly extended configuration. The backbone dynamics of the micelle-bound region are relatively uniform with a slight decrease in flexibility observed toward the C-terminal end. These results clarify the topological features of aS bound to membrane-mimicking detergent micelles, with implications for aS function and pathology. Keywords: Synuclein; Parkinsons; amyloid; protein aggregation; membrane-associated proteins; helix periodicity
Article published online ahead of print. Article and publication date are at http://www.proteinscience.org/cgi/doi/10.1110/ps.041255905.
| Introduction |
|---|
|
|
|---|
-Synuclein (aS) is a highly conserved presynaptic protein that plays a role in synaptic strength maintenance and dopamine homeostasis. Evidence that aS controls synaptic strength comes from neuronal cell line and knockout mouse models (Abeliovich et al. 2000; Murphy et al. 2000; Cabin et al. 2002; Schluter et al. 2003) that display impaired synaptic response to repetitive stimuli and alterations in the number of reserve pool vesicles, suggesting that aS regulates reserve synaptic vesicles called upon when readily releasable vesicles are exhausted. aS may accomplish this in part by interacting with and regulating phospholipase D (PLD) (Jenco et al. 1998; Ahn et al. 2002; Outeiro and Lindquist 2003; Payton et al. 2004), an enzyme with a purported role in vesicular trafficking (Liscovitch et al. 2000). aS also appears to be involved in regulating intracellular dopamine levels at several points of control. Expression of aS alters synaptic membrane permeability to dopamine by interacting with the human dopamine transporter (hDAT), resulting in withdrawal of hDAT from the external membrane (Lee et al. 2001; Wersinger and Sidhu 2003; Wersinger et al. 2003). aS can also block dopamine synthesis by inhibiting tyrosine hydroxylase (Perez et al. 2002). In addition, aS can influence the activity of the vesicular dopamine transporter VMAT2 (Lotharius et al. 2002). Several distinct conformations are potentially available to aS in vivo, including a free, intrinsically unstructured form (Weinreb et al. 1996) and a highly helical membrane associated form (Davidson et al. 1998). Based on the partial localization of aS to the surface of membranes (McLean et al. 2000; Cole et al. 2002) and synaptic vesicles (Iwai et al. 1995; Jensen et al. 1998) and on its functional association with several membrane-bound proteins such as PLD and hDAT, it is likely that the membrane bound form of the protein mediates its normal function(s). For the case of PLD interactions, this has been directly demonstrated (Payton et al. 2004). The specific form of aS that is responsible for its pathogenic role in vivo remains unclear. The protein is found aggregated into amyloid fibrils in the Lewy body deposits that are a characteristic hallmark of Parkinsons disease (PD) (Spillantini et al. 1997, 1998). The lipid-free protein can form similar amyloid fibrils in vitro (Hashimoto et al. 1998; Conway et al. 2000; Serpell et al. 2000), suggesting that this form of the protein may be important for in vivo pathogenesis. Thus, it is possible that lipid binding could deplete the pool of aggregation-competent aS in cells. It has also been shown, however, that lipid binding can promote the self assembly of aS (Perrin et al. 2001; Cole et al. 2002; Lee et al. 2002; Jo et al. 2004), suggesting that the membrane-bound state could play a role in generating toxic aggregates. Finally, although an aggregation related toxic gain of function is a popular model for how aS causes neuronal death, it remains possible that perturbations in the normal function of aS contribute to the development of PD, especially considering that aS function is intimately linked to dopamine homeostasis and that PD is a dopamine deficit disorder. In this case the lipid-bound structure of aS could again be expected to mediate the role of the protein in disease.
Because lipid-bound aS may be involved in both the normal and toxic functions of the protein, it is important to know the structure of the protein in this state. Previously, we showed that detergent micelles can be used to effectively mimic the effects of lipid binding on aS (Eliezer et al. 2001) and used NMR spectroscopy to characterize the local structure of aS bound to such lipid-mimetic micelles (Bussell and Eliezer 2003, 2004). We found that the protein is divided into a highly helical lipid-binding N-terminal domain and an unstructured lipid-free C-terminal domain. Based on a mismatch between the apolipoprotein-like 11-residue repeats of the aS primary sequence and the canonical
-helical periodicity of 3.6 residues per turn, we proposed that the helical structure we observed in aS may adopt an altered periodicity, completing three full turns every 11 residues, as had been previously proposed for the protein apolipoprotein A-I (Segrest et al. 1999). Nevertheless, our previous results did not provide a direct measurement of the helical periodicity of the aS structure. Here we use paramagnetic spin labels in combination with NMR to perform such a measurement. Our results confirm the presence of 11/3-periodic helical structure that is partially buried in the membrane surface and does not traverse the membrane interior. We also demonstrate that there are no long-range tertiary contacts between different helical regions of aS and characterize the backbone dynamics of the micelle-bound protein.
| Results |
|---|
|
|
|---|
Location of metal ions and spin labels with respect to the micelle
To characterize the location of the free metal ions and spin labels used in our studies with respect to the SDS micelle-forming detergent molecules, we measured the broadening of SDS acyl chain 13C NMR resonances induced in the presence of the various spin labels (data not shown). SDS carbon resonance assignments were based on a previous report (Kragh-Hansen and Riisom 1976) and resonances corresponding to carbons C1, C2, C3, C10, C11, and C12 (numbering from nearest to furthest from the sulfate group) were well resolved, whereas carbons C4C9 formed a condensed group of resonances that could not be easily distinguished from one another. The observed SDS broadening pattern was consistent with the chemical characteristics of each paramagnetic reagent. Mn2+ selectively broadened resonances C1 and C2 near the micelle surface with a weaker effect on the C4C9 cluster, consistent with exclusion of charged species from the micelle interior. On the other hand, the amphipathic small molecule 4-OH-TEMPO was found to be situated just below the micelle surface, broadening the C3 and C4C9 resonances more than those of C1 and C2. However, 4-OH-TEMPO does not completely penetrate the micelle interior as the resonances of C10 throughC12 were relatively unaffected. The doxyl moiety attached to stearate at position 5 embeds deeper within the micelle than 4-OH-TEMPO, selectively broadening the C3 and C4C9 resonances and having less effect on acyl carbons closer to the surface or further within. As expected, the deepest probe of the micelle interior was 16-doxylstearate, which selectively broadened the resonances of C11 and C12 at the micelle center. Thus the order of the four free paramagnetic reagents as a function of increasing distance from the micelle center is 16-doxylstearate, 5-doxylstearate, 4-OH-TEMPO, Mn2+.
Solvent accessibility of micelle-bound aS
The membrane-associated structure of aS is divided into an N-terminal membrane-binding region and a C-terminal membrane-free tail in the presence of either SDS micelles or lipid vesicles (Eliezer et al. 2001). The majority of the membrane binding region displays NMR C
chemical shifts and NOEs characteristic of helical structure, except for a small interruption near position 42, suggesting that membrane-bound aS forms a continuous helix with a single break (Bussell and Eliezer 2003). Sequence analysis suggests that this helix resides on the membrane surface and does not traverse the membrane (Davidson et al. 1998). To probe the solvent accessibility of aS bound to detergent micelles we measured the effect of the aqueous phase paramagnetic probe Mn2+ on aS NMR resonance intensities. Figure 1
shows NMR backbone resonance intensities from a protonnitrogen correlation spectrum of aS in the presence of Mn2+, normalized by their intensities in the absence of the broadening reagent. Resonances that are weakly or not broadened (values near 1 in the figure) correspond to locations in the protein backbone that are sequestered from the aqueous phase reagent. Within the N-terminal lipid-binding region of the protein (residues 1 ~94) there are three distinct maxima, centered around positions 10, 42, and 74, indicating that these regions are better protected from solvent than the remainder of the domain.
|
|
chemical shifts in this region (Bussell and Eliezer 2003), which although largely indicative of random coil, show two regions of similar shifts on either side of position 122, and by the dynamics data for both the free state (Bussell and Eliezer 2001) and lipid-bound state (data shown below) of the protein, which suggest a slightly lower mobility at position 122 than on either side.
Helix periodicity of micelle-bound aS
An additional and interesting observation is that throughout the lipid-binding region, there appears to be a three- to four-residue periodicity in the Mn2+ data. This periodicity is generally consistent with typical helical structure, where every third or fourth residue is found on the same face of a helix, and would therefore be better or more poorly shielded from solvent. In previous work, we suggested that the periodicity of the helical structure in lipid-bound aS may deviate from the canonical 3.6 residues per turn (or 18 residues per five full turns) of an
-helix and may instead reflect the 11-residue periodicity of the primary sequence by forming three full turns every 11 residues (Bussell and Eliezer 2003). The periodicity of spin label induced resonance broadening provides us with an opportunity to directly test this hypothesis. However, the effects of Mn2+ were observed to be quite strong, with large intensity differences between resonances from well-protected and poorly protected regions, making it difficult to analyze the underlying periodicity in the data. This may be a result of a high concentration of Mn2+ close to the negatively charged micelle surface, as mentioned above. Therefore, we decided to use micelle-resident spin labels, where the difference in distance between the spin label and either side of a surface bound helix might be expected to be smaller, leading to a more even broadening effect.
Protonnitrogen correlation spectra of aS bound to micelles in the presence of 5-doxylstearate, 16-doxylstearate, and 4-OH-TEMPO displayed resonance broadening that was more uniform across the lipid-binding domain of aS and that exhibited a three- to four-residue periodicity, as expected (not shown). To evaluate whether the periodicity in the data could be used to discriminate between the two types of helix periodicity being considered (three full turns over 11 residues or five turns over 18 residues) we analyzed resonance intensities as a function of the angle at which each residue would lie on a helical pinwheel diagram for each possible periodicity. For an 11/3 helix, each residue would fall at one of 11 possible azimuthal angles, whereas for a canonical 18/5 helix, 18 such angles are possible. When plotted against the correct periodicity, the broadening data should yield a sine wave, reflecting the oscillation in the distance between each successive helix site and the micelle-resident spin label. If a sine wave is not observed, this implies a mismatch between the periodicity of the data and that of the model. Figure 3
shows the average intensity of resonances originating from each azimuthal position in an 11/3 and an 18/5 model of the aS lipid-binding domain for each of the three micelle-resident spin labels, 5-doxylstearate, 16-doxylstearate, and 4-OH-TEMPO. All three data sets show a sinusoidal modulation when plotted according to the 11/3 model, whereas no such modulation is seen in plots generated according to the canonical 18/5 model. These results demonstrate that the fundamental periodicity of the helical structure of micelle-bound aS is 11 residues per three full turns. Note that data from the membrane-free unstructured C-terminal region do not correlate to either helical model, consistent with the absence of helical structure in this region (not shown).
|
Finally, the phase of the sinusoidal broadening profiles induced by all three micelle embedded spin labels (Fig. 3
) is the same. Spin labels on opposite sides of the helix backbone would induce broadening profiles with the same periodicity but with an opposite relative phase. Therefore, we can conclude that all three spin label moieties lie deeper within the micelle than the aS backbone. Collectively these spin labels probe the region from acyl carbon C12 at the center of the micelle to carbon C4 just below the head group region suggesting that on average, the aS backbone penetrates no deeper into micelles than SDS carbon C4. This result is consistent with a recent ESR study of acyl chain disordering by aS (Ramakrishnan et al. 2003).
Helix curvature of micelle-bound aS
In our working model of lipid-bound aS, the protein binds to the surface of membranes in an
1/3-helical conformation that places its hydrophobic face in continuous contact with the membrane. This would be expected to cause aS to curve in a manner similar to that of other membrane-surface associated helices (Chou et al. 2002). Such curvature, in combination with the difference in the dielectric constant of the hydrocarbon and the aqueous environments, tends to decrease hydrogen bond lengths for regions of the backbone facing the membrane relative to solvent exposed regions. Any such shortening of hydrogen bonds should again reflect the intrinsic periodicity of the helix. Therefore, we investigated the helix curvature of micelle-bound aS by measuring the deviation of NMR amide proton chemical shifts from their expected random coil values. These chemical shifts are sensitive to the length of backbone hydrogen bonds in helices, with longer hydrogen bond lengths leading to smaller (more negative) amide proton chemical shift deviations (Zhou et al. 1992). Figure 4
shows the amide proton chemical shift deviations of micelle-bound aS plotted as a function of the predicted azimuthal angle for 11/3 and 18/5 helical periodicities. When plotted according to the 11/3 model of the membrane-binding helical region (Fig. 4A
) the data show a sinusoidal modulation that is not present when the data are plotted according to the canonical 18/5 helical model (Fig. 4B
). This again confirms the 11/3 periodicity of the aS helical structure, and also confirms that this structure curves toward the detergent micelle. The phase of the sinusoidal data also shows that the hydrophobic face of the helical aS structure exhibits the greatest shortening of hydrogen bond lengths, consistent with the expected exposure of this face to the membrane.
|
|
|
| Discussion |
|---|
|
|
|---|
This evidence is consistent with and complementary to recent results of ESR measurements, which also support an 11/3 periodicity in lipid-bound aS (Jao et al. 2004). While the ESR data probed a relatively limited region of the protein, the NMR data reflect the entire lipid-binding domain. In addition the NMR approach is less likely to perturb either the proteins structure or its interactions with lipid surfaces since neither modification of the proteins sequence nor direct attachment of a spin label to the protein are required. The detailed structural parameters associated with this unusual helical periodicity and how they compare with those found in more typical
-helical structure remain to be elucidated, as pointed out also by Jao et al. (2004). In particular it is noteworthy that most helices even in globular proteins are amphipathic, curved, and have a range of periodicities (Blundell et al. 1983). Nevertheless, it appears that the 11/3 periodicity is sufficiently different structurally and functionally to be uniquely suited for a certain type of lipid interaction that is exemplified by aS and the apolipoprotein family, as well as by several other families of reversibly lipid-binding proteins that we identified previously in a protein sequence database search (Bussell and Eliezer 2003).
By using both an aqueous phase spin label and spin labels residing at different depths within the micelle we are also able to provide insights into the depth of penetration of the helical structure of aS into the hydrophobic micelle or lipid bilayer interior, as well as into the determinants of this depth. All three micelle-resident spin labels were shown to be on the same side of the helical aS structure, confirming that this structure resides entirely on the surface of the micelle or bilayer, and does not traverse the hydrophobic interior. Also, by explicitly determining the location of the TEMPO spin label to be nearest to the C3 and C4 carbons of SDS, we show that the protein backbone does not on average settle deeper than this into the hydrophobic interior and therefore remains close to the headgroup region. However, our data also show that not all regions of the protein penetrate beyond the headgroup region to the same extent. In particular the sixth of the seven 11-residue repeats of the protein is submerged deeper below the headgroup region than the remainder of the protein, precluding access by the aqueous spin label reagent Mn2+. This observation is interesting for several reasons. First, this repeat is the only aS repeat that lacks either of the highly conserved lysine residues that are found at the interface between the hydrophobic and hydrophilic faces of the membrane-bound helical structure of the protein. These lysines have been predicted to anchor this class of lipid-binding amphipathic helices (also called type A2 helices) just below the lipid headgroup region by extending upward from the hydrophobic layer below and interacting with negatively charged headgroups (Segrest et al. 1992). This interaction is thought to be partly behind the specificity of aS binding to membranes containing negatively charged lipids (Davidson et al. 1998; Jo et al. 2000; Bussell and Eliezer 2004) and the documented role of electrostatics in such binding (Davidson et al. 1998; Jo et al. 2000). The fact that the only aS repeat lacking interfacial lysines sits deeper below the headgroup region than the remainder of the protein provides significant support for the idea that the lysines play a critical role in determining the penetration depth of helices into membranes (the snorkeling model; Segrest et al. 1992).
Although the absence of lysines in repeat six of aS likely underlies the deeper burial of this repeat in the membrane, the consequences of this burial for the function of the protein and its role in disease are less clear. From the perspective of normal aS function, this repeat lies in the middle of a region that was recently demonstrated to be important for inhibition of PLD2 (Payton et al. 2004), one of the few well-documented functional roles of aS (Jenco et al. 1998; Ahn et al. 2002; Outeiro and Lindquist 2003). This inhibition requires aS to be in its membrane-bound helical conformation, suggesting a direct interaction between helical regions of aS and membrane-associated PLD2 (Payton et al. 2004). Interestingly, PLD2 is also inhibited by
-Synuclein (bS), a closely related homolog of aS, which is, however, missing residues corresponding to aS residues 7484 (Jenco et al. 1998; Payton et al. 2004). Although these missing residues include part of aS repeat six, the resulting sixth repeat of bS also lacks any interfacial lysines (Fig. 2
), suggesting that it would similarly be submerged more deeply in the membrane than other bS repeats. Therefore, it is possible that the functional interactions between PLD2 and aS or bS depend on the depth of burial of repeat six within the lipid bilayer.
A third interesting feature of aS repeat six is that it corresponds quite closely to a 12-residue stretch of the protein (residues 7182) that was identified as a potential nucleation site for aggregation of aS into amyloid fibrils (Giasson et al. 2001). Burial of this region in the membrane could have consequences for aS aggregation irrespective of whether aS amyloid fibril formation occurs via the highly unstructured cytoplasmic form of the protein or the lipid-bound form in vivo, a question that remains open. If aggregation occurs from the membrane-associated state, the deeper submersion of repeat six in the membrane would suggest that its role in nucleation would occur in the context of a highly hydrophobic environment, which would significantly alter the relative strengths of the interactions involved. On the other hand in the cytoplasm the lack of charge that apparently leads to submersion of repeat six could play a significant role in driving this region to seek intermolecular interactions in order to escape the polar aqueous environment.
In addition to elucidating structural features of aS such as helical periodicity and depth of burial that are intrinsically related to its interactions with the micelle or lipid surface, our results also shed new light on the global topology of the protein. In earlier work, we posited based on the low dispersion of amide proton chemical shifts in protonnitrogen correlation spectra that micelle-bound aS was unlikely to adopt a compact globular conformation with tertiary interactions (Eliezer et al. 2001), and this was supported by our inability to observe long-range NOEs (Bussell and Eliezer 2003). By using spin labels attached to different sites in aS, we are now able to directly confirm the highly extended nature of the helical structure of micelle-bound aS. This methodology enables us to observe the approach of any region of the protein to within 15 Å of any of the labeled sites, essentially providing a long-range NOE capability. Our data convincingly demonstrate that at no point do regions of the membrane-binding domain of aS that are distant in sequence approach one another closely in space, confirming the lack of any long-range tertiary interactions and ruling out the possibility of hairpin formation around the one break in the continuously helical structure. This result is again consistent with recently reported ESR studies of lipid-bound aS, which indicated an absence of long-range interactions based on the lineshapes of spin labels attached to various sites in the protein (Jao et al. 2004). The ESR lineshapes, however, are only evaluated in terms of the general environment of the spin label (i.e., surface exposed or buried) and are not directly sensitive to spatial proximity in the way that NMR signal intensities are.
Recently it was also proposed that the break in the helical structure that is evident in NMR data of micelle-bound aS may not exist in the lipid vesicle-bound form of the protein (Jao et al. 2004). This argument was based on ESR data showing a lack of flexibility and membrane interactions at the site of the break in the vesicle-bound state. However, the results we report here for the micelle-bound protein are entirely consistent with these ESR observations, showing that residues 4244 do not exhibit greater flexibility than the remainder of the protein (Fig. 6
), and that these sites are indeed buried deeper within the membrane than the surrounding regions (Fig. 1
). Therefore, it appears that the micelle- and lipid-bound forms of the protein behave similarly at this location, and that it is premature to conclude that the interruption of the helical structure of aS does not occur in the lipid vesicle-bound state of the protein. We have not characterized the precise nature of this interruption beyond the requirement that it lead to random coil-like C
chemical shifts and weaker interresidue amide proton NOEs (Bussell and Eliezer 2003), but it appears likely that it is not a flexible loop region, but rather a short and somewhat ordered deviation from helical structure into the membrane interior. It is also worth noting that although a spherical detergent micelle would indeed present a very highly curved surface for interacting with a single long aS helix, we do not as of yet have any information regarding the geometry of the micelle in the aSmicelle complex, and the presence of the protein may cause this geometry to deviate significantly from that of a sphere.
Conclusions
We have provided direct evidence that the helical structure of membrane-bound aS adopts the unusual 11/3 periodicity that we proposed previously. In addition, we have demonstrated that this lipid-associated helical structure does not traverse the membrane interior and is highly extended, lacking any long-range tertiary structure. We also determined that the sixth of the seven 11-residue repeats of aS is submerged more deeply within the membrane than the remainder of the protein, suggesting that interfacial lysines in the other repeats play a key role in positioning the protein on the membrane surface. Finally, our results also indicate that the one break in this extended helical structure is probably ordered and lies deeper within the membrane, and suggest that this break is preserved even when the protein is bound to lipid vesicles. Taken together, these observations considerably improve our view of the structure of lipid-bound aS and bring into focus a number of interesting questions. What is the precise role of the unusual 11/3 helical periodicity in facilitating the reversible lipid interactions of aS and other proteins containing this motif? How does the repetitive and highly extended structure of the lipid-binding domain engage in specific interactions with proteins such as PLD? Is the deeper burial of repeat six functionally significant, and if so, is a functional requirement responsible for the very features that make this repeat an amyloid fibril nucleation site? What is the precise structure adopted at the break in the helical conformation of the lipid-bound protein and what, if any, is its functional role? Future experiments designed to answer these questions are expected to further improve our understanding of the biology and pathology associated with this PD-linked protein.
| Materials and methods |
|---|
|
|
|---|
Free spin label compounds were added to protein samples using concentrated stock solutions and then gently but thoroughly mixed before transfer to the NMR tube. Final concentrations of the four free spin labels were 100 µM MnCl2, 10 µM 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (4-OH-TEMPO), 0.7 mM 5- and 16-doxylstearate. The highly reactive thiol-specific spin label 1-oxyl-2,2,5,5-tetramethyl-3-pyrroline-3-methyl methanethiosulfonate (MTSL, Toronto Research Chemicals) was attached to cysteine sites introduced into the aS sequence using site-directed mutagen-esis at positions 9, 20, 31, 42, 50, 61, 72, 83, and 93. Spin labeled protein was prepared by adding a 10-fold excess of spin label to freshly prepared samples of protein. Excess spin label was not removed from the samples, as nonspecific interactions between the spin label and the protein were not anticipated to be significant.
| Acknowledgments |
|---|
Note added in proof
While this paper was under review two new manuscripts appeared (Ulmer et al. 2004; Bisaglia et al. 2005) describing complementary studies of the structure and dynamics of micelle-bound aS. The results presented are generally consistent with our own findings. Ulmer et al. (2004) use a paramagnetic label at position 87 to detect a proximity between the two helical segments of aS, while our data, especially from samples spin-labeled at positions 72, 61, 20, and 9, do not show significant broadening at locations that would most closely approach them in the apposing helix. This could result from the spin labels adopting orientations that place them too far from the apposing helix, or it could reflect an altered topology in the truncated construct that we used for our PRE measurements. Further efforts will be required to clarify this issue.
| References |
|---|
|
|
|---|
-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25: 239252.[CrossRef][Medline]
Ahn, B.H., Rhim, H., Kim, S.Y., Sung, Y.M., Lee, M.Y., Choi, J.Y., Wolozin, B., Chang, J.S., Lee, Y.H., Kwon, T.K., et al. 2002.
-Synuclein interacts with phospholipase D isozymes and inhibits pervanadate-induced phospholipase D activation in human embryonic kidney-293 cells. J. Biol. Chem. 277: 1233412342.
Bisaglia, M., Tessari, I., Pinato, L., Bellanda, M., Giraudo, S., Fasano, M., Bergantino, E., Bubacco, L., and Mammi, S. 2005. A topological model of the interaction between
-synuclein and sodium dodecyl sulfate micelles. Biochemistry 44: 329339.[CrossRef][Medline]
Blundell, T., Barlow, D., Borkakoti, N., and Thornton, J. 1983. Solvent-induced distortions and the curvature of
-helices. Nature 306: 281283.[CrossRef][Medline]
Bussell Jr., R. and Eliezer, D. 2001. Residual structure and dynamics in Parkinsons disease-associated mutants of
-synuclein. J. Biol. Chem. 276: 4599646003.
. 2003. A structural and functional role for 11-mer repeats in
-synuclein and other exchangeable lipid binding proteins. J. Mol. Biol. 329: 763778.[CrossRef][Medline]
. 2004. Effects of Parkinsons disease-linked mutations on the structure of lipid-associated
-synuclein. Biochemistry 43: 48104818.[CrossRef][Medline]
Cabin, D.E., Shimazu, K., Murphy, D., Cole, N.B., Gottschalk, W., McIlwain, K.L., Orrison, B., Chen, A., Ellis, C.E., Paylor, R., et al. 2002. Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking
-synuclein. J. Neurosci. 22: 87978807.
Chandra, S., Chen, X., Rizo, J., Jahn, R., and Sudhof, T.C. 2003. A broken
-helix in folded
-Synuclein. J. Biol. Chem. 278: 1531315318.
Chou, J.J., Kaufman, J.D., Stahl, S.J., Wingfield, P.T., and Bax, A. 2002. Micelle-induced curvature in a water-insoluble HIV-1 Env peptide revealed by NMR dipolar coupling measurement in stretched polyacrylamide gel. J. Am. Chem. Soc. 124: 24502451.[CrossRef][Medline]
Cole, N.B., Murphy, D.D., Grider, T., Rueter, S., Brasaemle, D., and Nussbaum, R.L. 2002. Lipid droplet binding and oligomerization properties of the Parkinsons disease protein
-synuclein. J. Biol. Chem. 277: 63446352.
Conway, K.A., Harper, J.D., and Lansbury Jr., P.T. 2000. Fibrils formed in vitro from
-synuclein and two mutant forms linked to Parkinsons disease are typical amyloid. Biochemistry 39: 25522563.[CrossRef][Medline]
Davidson, W.S., Jonas, A., Clayton, D.F., and George, J.M. 1998. Stabilization of
-synuclein secondary structure upon binding to synthetic membranes. J. Biol. Chem. 273: 94439449.
Eliezer, D., Kutluay, E., Bussell Jr., R., and Browne, G. 2001. Conformational properties of
-synuclein in its free and lipid-associated states. J. Mol. Biol. 307: 10611073.[CrossRef][Medline]
Fernandez, C.O., Hoyer, W., Zweckstetter, M., Jares-Erijman, E.A., Subramaniam, V., Griesinger, C., and Jovin, T.M. 2004. NMR of
-synuclein-polyamine complexes elucidates the mechanism and kinetics of induced aggregation. EMBO J. 23: 20392046.[CrossRef][Medline]
Giasson, B.I., Murray, I.V., Trojanowski, J.Q., and Lee, V.M. 2001. A hydrophobic stretch of 12 amino acid residues in the middle of
-synuclein is essential for filament assembly. J. Biol. Chem. 276: 23802386.
Gillespie, J.R. and Shortle, D. 1997. Characterization of long-range structure in the denatured state of staphylococcal nuclease. I. Paramagnetic relaxation enhancement by nitroxide spin labels. J. Mol. Biol. 268: 158169.[CrossRef][Medline]
Hashimoto, M., Hsu, L.J., Sisk, A., Xia, Y., Takeda, A., Sundsmo, M., and Masliah, E. 1998. Human recombinant NACP/
-synuclein is aggregated and fibrillated in vitro: Relevance for Lewy body disease. Brain Res. 799: 301306.[CrossRef][Medline]
Iwai, A., Masliah, E., Yoshimoto, M., Ge, N., Flanagan, L., de Silva, H.A., Kittel, A., and Saitoh, T. 1995. The precursor protein of non-A
component of Alzheimers disease amyloid is a presynaptic protein of the central nervous system. Neuron 14: 467475.[CrossRef][Medline]
Jao, C.C., Der-Sarkissian, A., Chen, J., and Langen, R. 2004. Structure of membrane-bound
-synuclein studied by site-directed spin labeling. Proc. Natl. Acad. Sci. 101: 83318336.
Jenco, J.M., Rawlingson, A., Daniels, B., and Morris, A.J. 1998. Regulation of phospholipase D2: Selective inhibition of mammalian phospholipase D iso-enzymes by
- and
-synucleins. Biochemistry 37: 49014909.[CrossRef][Medline]
Jensen, P.H., Nielsen, M.S., Jakes, R., Dotti, C.G., and Goedert, M. 1998. Binding of
-synuclein to brain vesicles is abolished by familial Parkinsons disease mutation. J. Biol. Chem. 273: 2629226294.
Jo, E., McLaurin, J., Yip, C.M., St. George-Hyslop, P., and Fraser, P.E. 2000.
-Synuclein membrane interactions and lipid specificity. J. Biol. Chem. 275: 3432834334.
Jo, E., Darabie, A.A., Han, K., Tandon, A., Fraser, P.E., and McLaurin, J. 2004.
-Synuclein-synaptosomal membrane interactions: Implications for fibrillogenesis. Eur. J. Biochem. 271: 31803189.[Medline]
Jones, M.K., Anantharamaiah, G.M., and Segrest, J.P. 1992. Computer programs to identify and classify amphipathic
helical domains. J. Lipid Res. 33: 287296.[Abstract]
Kragh-Hansen, U. and Riisom, T. 1976. Complexes of aliphatic sulfates and human-serum albumin studied by 13C nuclear-magnetic-resonance spectroscopy. Eur. J. Biochem. 70: 1523.[Medline]
Lee, F.J., Liu, F., Pristupa, Z.B., and Niznik, H.B. 2001. Direct binding and functional coupling of
-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis. FASEB J. 15: 916926.
Lee, H.J., Choi, C., and Lee, S.J. 2002. Membrane-bound
-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form. J. Biol. Chem. 277: 671678.
Liscovitch, M., Czarny, M., Fiucci, G., and Tang, X. 2000. Phospholipase D: Molecular and cell biology of a novel gene family. Biochem. J. 345: 401415.
Lotharius, J., Barg, S., Wiekop, P., Lundberg, C., Raymon, H.K., and Brundin, P. 2002. Effect of mutant
-synuclein on dopamine homeostasis in a new human mesencephalic cell line. J. Biol. Chem. 277: 3888438894.
McLean, P.J., Kawamata, H., Ribich, S., and Hyman, B.T. 2000. Membrane association and protein conformation of
-synuclein in intact neurons. Effect of Parkinsons disease-linked mutations. J. Biol. Chem. 275: 88128816.
Murphy, D.D., Rueter, S.M., Trojanowski, J.Q., and Lee, V.M. 2000. Synucleins are developmentally expressed, and
-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J. Neurosci. 20: 32143220.
Outeiro, T.F. and Lindquist, S. 2003. Yeast cells provide insight into
-synuclein biology and pathobiology. Science 302: 17721775.
Payton, J.E., Perrin, R.J., Woods, W.S., and George, J.M. 2004. Structural determinants of PLD2 inhibition by
-synuclein. J. Mol. Biol. 337: 10011009.[CrossRef][Medline]
Perez, R.G., Waymire, J.C., Lin, E., Liu, J.J., Guo, F., and Zigmond, M.J. 2002. A role for
-synuclein in the regulation of dopamine biosynthesis. J. Neurosci. 22: 30903099.
Perrin, R.J., Woods, W.S., Clayton, D.F., and George, J.M. 2001. Exposure to long chain polyunsaturated fatty acids triggers rapid multimerization of synucleins. J. Biol. Chem. 276: 4195841962.
Ramakrishnan, M., Jensen, P.H., and Marsh, D. 2003.
-Synuclein association with phosphatidylglycerol probed by lipid spin labels. Biochemistry 42: 1291912926.[CrossRef][Medline]
Schluter, O.M., Fornai, F., Alessandri, M.G., Takamori, S., Geppert, M., Jahn, R., and Sudhof, T.C. 2003. Role of
-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice. Neuroscience 118: 9851002.[CrossRef][Medline]
Segrest, J.P., Jones, M.K., De Loof, H., Brouillette, C.G., Venkatachalapathi, Y.V., and Anantharamaiah, G.M. 1992. The amphipathic helix in the exchangeable apolipoproteins: A review of secondary structure and function. J. Lipid Res. 33: 141166.[Abstract]
Segrest, J.P., Jones, M.K., Klon, A.E., Sheldahl, C.J., Hellinger, M., De Loof, H., and Harvey, S.C. 1999. A detailed molecular belt model for apolipo-protein A-I in discoidal high density lipoprotein. J. Biol. Chem. 274: 3175531758.
Segrest, J.P., Jones, M.K., Mishra, V.K., and Anantharamaiah, G.M. 2002. Experimental and computational studies of the interactions of amphipathic peptides with lipid surfaces. In Current topics in membranes (eds. S.A. Simon and T.J. McIntosh), p. 330. Academic Press, New York.
Serpell, L.C., Berriman, J., Jakes, R., Goedert, M., and Crowther, R.A. 2000. Fiber diffraction of synthetic
-synuclein filaments shows amyloid-like cross-
conformation. Proc. Natl. Acad. Sci. 97: 48974902.
Spillantini, M.G., Schmidt, M.L., Lee, V.M., Trojanowski, J.Q., Jakes, R., and Goedert, M. 1997.
-Synuclein in Lewy bodies. Nature 388: 839840.[CrossRef][Medline]
Spillantini, M.G., Crowther, R.A., Jakes, R., Hasegawa, M., and Goedert, M. 1998.
-Synuclein in filamentous inclusions of Lewy bodies from Parkinsons disease and dementia with lewy bodies. Proc. Natl. Acad. Sci. 95: 64696473.
Ulmer, T.S., Bax, A., Cole, N.B., and Nussbaum, R.L. 2004. Structure and dynamics of micelle-bound human
-synuclein. J. Biol. Chem. http://www.jbc.org.
Weinreb, P.H., Zhen, W., Poon, A.W., Conway, K.A., and Lansbury Jr., P.T. 1996. NACP, a protein implicated in Alzheimers disease and learning, is natively unfolded. Biochemistry 35: 1370913715.[CrossRef][Medline]
Wersinger, C. and Sidhu, A. 2003. Attenuation of dopamine transporter activity by
-synuclein. Neurosci. Lett. 340: 189192.[CrossRef][Medline]
Wersinger, C., Prou, D., Vernier, P., Niznik, H.B., and Sidhu, A. 2003. Mutations in the lipid-binding domain of
-synuclein confer overlapping, yet distinct, functional properties in the regulation of dopamine transporter activity. Mol. Cell Neurosci. 24: 91105.[CrossRef][Medline]
Wishart, D.S., Bigam, C.G., Holm, A., Hodges, R.S., and Sykes, B.D. 1995. 1H, 13C and 15N random coil NMR chemical shifts of the common amino acids. I. Investigations of nearest-neighbor effects. J. Biomol. NMR 5: 6781.[CrossRef][Medline]
Zhou, N.E., Zhu, B.Y., Sykes, B.D., and Hodges, R.S. 1992. Relationship between amide proton chemical shifts and hydrogen bonding in amphipathic
-helical peptides. J. Am. Chem. Soc. 114: 43204326.[CrossRef]
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
I. M.J. Segers-Nolten, M. M.M. Wilhelmus, G. Veldhuis, B. D. van Rooijen, B. Drukarch, and V. Subramaniam Tissue transglutaminase modulates {alpha}-synuclein oligomerization Protein Sci., August 1, 2008; 17(8): 1395 - 1402. [Abstract] [Full Text] [PDF] |
||||
![]() |
|